BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sasaki N, Toyoda M. Vascular Diseases and Gangliosides. Int J Mol Sci 2019;20:E6362. [PMID: 31861196 DOI: 10.3390/ijms20246362] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
Number Citing Articles
1 Rong T, Wei B, Ao M, Zhao H, Li Y, Zhang Y, Qin Y, Zhou J, Zhou F, Chen Y. Enhanced Anti-Atherosclerotic Efficacy of pH-Responsively Releasable Ganglioside GM3 Delivered by Reconstituted High-Density Lipoprotein. Int J Mol Sci 2021;22:13624. [PMID: 34948420 DOI: 10.3390/ijms222413624] [Reference Citation Analysis]
2 Di Carluccio C, Forgione RE, Bosso A, Yokoyama S, Manabe Y, Pizzo E, Molinaro A, Fukase K, Fragai M, Bensing BA, Marchetti R, Silipo A. Molecular recognition of sialoglycans by streptococcal Siglec-like adhesins: toward the shape of specific inhibitors. RSC Chem Biol 2021;2:1618-30. [PMID: 34977577 DOI: 10.1039/d1cb00173f] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Furukawa K. Editorial for Special Issue "Gangliosides: Modes of Action and Cell Fates". Int J Mol Sci 2020;21:E6552. [PMID: 32911611 DOI: 10.3390/ijms21186552] [Reference Citation Analysis]